Literature DB >> 15082840

Use of diuretics in cardiovascular diseases: (1) heart failure.

S U Shah1, S Anjum, W A Littler.   

Abstract

Diuretics are used extensively in hospitals and in community medical practice for the management of cardiovascular diseases. They are used frequently as the first line treatment for mild to moderate hypertension and are an integral part of the management of symptomatic heart failure. Although diuretics have been used for several decades, there is still some ambiguity and confusion regarding the optimal way of using these common drugs. In this paper, the classes and action of diuretics are reviewed, and the various indications, optimal doses, and recommendations on the effective use of these agents are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082840      PMCID: PMC1742985          DOI: 10.1136/pgmj.2003.010835

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  41 in total

1.  Diuretic therapy, hypertension, and cardiac arrest.

Authors:  J T Bigger
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

Review 2.  The renal H-K-ATPase: physiological significance and role in potassium homeostasis.

Authors:  C S Wingo; B D Cain
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

3.  Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.

Authors:  C M Canessa; L Schild; G Buell; B Thorens; I Gautschi; J D Horisberger; B C Rossier
Journal:  Nature       Date:  1994-02-03       Impact factor: 49.962

4.  The pharmacodynamics of torsemide in patients with congestive heart failure.

Authors:  D Vargo; W G Kramer; P K Black; W B Smith; T Serpas; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1994-07       Impact factor: 6.875

Review 5.  Haemodynamic impact of diuretic therapy in chronic heart failure.

Authors:  B Silke
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

6.  Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes.

Authors:  P Daleau; J Turgeon
Journal:  Circ Res       Date:  1994-06       Impact factor: 17.367

7.  Thiazides and bone mineral density in elderly men and women.

Authors:  D J Morton; E L Barrett-Connor; S L Edelstein
Journal:  Am J Epidemiol       Date:  1994-06-01       Impact factor: 4.897

8.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine.

Authors:  S Greenberg; C McGowan; J Xie; W R Summer
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

10.  Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.

Authors:  J M Good; A J Brady; F H Noormohamed; C M Oakley; J G Cleland
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

View more
  4 in total

Review 1.  Pediatric Ototoxicity: Current Trends and Management.

Authors:  Brian J Fligor
Journal:  Semin Hear       Date:  2019-04-26

Review 2.  Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches.

Authors:  Claudio Ronco; Luca Di Lullo
Journal:  Kidney Dis (Basel)       Date:  2016-09-10

Review 3.  Cardiorenal syndrome type 2: from diagnosis to optimal management.

Authors:  Renato De Vecchis; Cesare Baldi
Journal:  Ther Clin Risk Manag       Date:  2014-11-12       Impact factor: 2.423

4.  Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist.

Authors:  Tyler C Beck; Matthew A Hapstack; Gautam S Ghatnekar; Thomas A Dix
Journal:  Med Sci (Basel)       Date:  2019-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.